CANCER.

Information on current developments in both regular and alternative or complementary treatments for cancer types and resources at all stages. We have basically all articles and information put in alphabetical order, scroll in left column in alphabetical list.

Experiences of cancer patients with complementary approaches can be found by experience stories and there are also some videos of experiences of cancer patients to see. To click on video button top left . Or visit the website of the SNFK information where movies are shown on complementary approaches to cancer.

Erbitux - a monoclonal plea, if given irinotecan chemotherapy in addition to a significant positive outcome on survival in metastatic colorectal cancer, but only in cancer patients with KRAS wild gene mutation. Article updated April 13, 2009

  • Erbitux - a monoclonal plea, if given irinotecan chemotherapy in addition to a significant positive outcome on survival in metastatic colorectal cancer, but only in cancer patients with KRAS wild gene mutation. Article updated April 13, 2009